Central office: Isaac Newton Street – Naorte Building 07121 – Palma de Mallorca

Perinatal Nutrition

During critical periods of perinatal development, nutrition and other environmental stimuli influence the development of the newborn and can induce permanent changes in its metabolism and susceptibility to chronic diseases, including obesity. These aspects that more or less permanently condition growth and the adult phenotype are called metabolic programming or "imprinting". In this regard, maternal obesity during pregnancy and lactation, as well as maternal diet in this perinatal stage, can change the metabolic programming of neural networks in the offspring, for example, perpetuating or even amplifying the susceptibility to obesity in offspring through generations.  

Thus, it is important to ensure that perinatal nutrition is optimal to allow for healthy growth and development and to address potential long-term detrimental effects.

leptin

baby-g9a88cc079_1920

Alimentómica cannot be left out of the challenges posed by the global obesity epidemic, and its first line of research, the leptin project, aims to contribute to a new strategy for obesity prevention.

In 1994 it was discovered leptin, a protein hormone secreted by adipose tissue that modulates energy intake and expenditure. Today we know that alterations in the production of leptin or their receptors in the central nervous system cause obesity in humans.

The discovery of leptin meant an enormous advance in the knowledge of the molecular biology of the body weight and obesity control system. However, the use of leptin to try to cure obesity has not fulfilled the initial expectations, since in most obese humans the problem is not a lack of leptin, but a resistance to the effects of this hormone.

However, at the end of 2005, the Biochemistry, Molecular Biology, Nutrition and Biotechnology (Nutrigenomics) research group, currently Nutrigenomics, Biomarkers and Risk Assessment (NuBE), of the University of the Balearic Islands  led by the Prof. Catalina Picó, obtained evidence that obesity can be prevented by ingesting moderate amounts of leptin during lactation. In fact, leptin is naturally present in breast milk but not in current commercial infant formulas. This discovery would explain, in part, why breastfeeding (which provides leptin) prevents the development of obesity and other disorders compared to formula feeding (which does not provide leptin). The group has also obtained evidence that, in humans, the weight at two years correlates negatively with the amount of leptin provided by breast milk, so that the higher the concentration of leptin in breast milk, the lower the mass index body at two years. In addition, animal studies of the group show that the intake of moderate amounts of leptin during lactation is capable of reversing most of the maladjustment caused by adverse nutritional conditions during pregnancy; evidencing, even more, the essential role of a sufficient intake of leptin during the lactation period and the importance of breastfeeding in the prevention of developing obesity.

Other compounds

Not only leptin present in breast milk may be affecting the predisposition of children to develop obesity and metabolic diseases in adulthood. Other components of milk can be decisive in the aforementioned perinatal programming. A) Yes, Alimentómica continues to investigate every day in the characterization of those components of breast milk that can affect the metabolic programming of obesity and metabolic syndrome, as well as lifestyle strategies that mothers could adopt, especially those who are overweight or diabetic, to modulate and optimize breast milk in order to reverse the potential programmed susceptibility of their children to develop these diseases.

en_USEnglish